Gossamer Bio Balance Sheet Health
Financial Health criteria checks 5/6
Gossamer Bio has a total shareholder equity of $62.8M and total debt of $209.0M, which brings its debt-to-equity ratio to 333%. Its total assets and total liabilities are $311.9M and $249.1M respectively.
Key information
333.0%
Debt to equity ratio
US$209.02m
Debt
| Interest coverage ratio | n/a |
| Cash | US$296.43m |
| Equity | US$62.77m |
| Total liabilities | US$249.15m |
| Total assets | US$311.92m |
Recent financial health updates
Health Check: How Prudently Does Gossamer Bio (NASDAQ:GOSS) Use Debt?
Jun 25
Gossamer Bio (NASDAQ:GOSS) Has Debt But No Earnings; Should You Worry?
Jan 19Is Gossamer Bio (NASDAQ:GOSS) A Risky Investment?
Sep 22Recent updates
Peaking Back In On Gossamer Bio
Sep 27Gossamer Bio to raise $120M in a private equity placement
Jul 13Health Check: How Prudently Does Gossamer Bio (NASDAQ:GOSS) Use Debt?
Jun 25Gossamer Bio (NASDAQ:GOSS) Has Debt But No Earnings; Should You Worry?
Jan 19Is Gossamer Bio (NASDAQ:GOSS) A Risky Investment?
Sep 22Need To Know: Gossamer Bio, Inc. (NASDAQ:GOSS) Insiders Have Been Buying Shares
Jan 28Gossamer Bio (GOSS) Investor Presentation - Slideshow
Nov 18Financial Position Analysis
Short Term Liabilities: GOSS's short term assets ($306.5M) exceed its short term liabilities ($51.6M).
Long Term Liabilities: GOSS's short term assets ($306.5M) exceed its long term liabilities ($197.5M).
Debt to Equity History and Analysis
Debt Level: GOSS has more cash than its total debt.
Reducing Debt: GOSS's debt to equity ratio has increased from 0% to 333% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GOSS has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: GOSS has sufficient cash runway for 2.5 years if free cash flow continues to reduce at historical rates of 18.4% each year.